-
Convergent Therapeutics Announces Two Clinical Trial Updates on CONV01-α at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium 2025
10 Feb 2025 22:20 GMT
… treatment of advanced prostate cancer. The study … progressive metastatic castration-resistant prostate cancer (mCRPC). Relatively low … with castration-resistant prostate cancer. Philip Kantoff, … therapeutics-announces-two-clinical-trial-updates-on-conv01-- …
-
Implementing and Optimizing Universal Germline Genetic Testing for Patients with Prostate Cancer in Clinical Practice Consider.
10 Feb 2025 13:20 GMT
… testing (UGGT) in prostate cancer and provide practical recommendations … testing (GGT) in prostate cancer have progressed, usage … 1 inhibitors) and potential clinical trials. Despite these benefits, … In March 2024, prostate cancer experts convened to discuss …
-
NSW new new radiation therapy cuts prostate cancer treatment times by more than half
10 Feb 2025 01:07 GMT
… 20 sessions.
Local and international clinical trials have shown the shorter course … difference to those living with prostate cancer, the most commonly diagnosed cancer … Saffin:
“This shorter course of prostate cancer treatment offers multiple benefits for …
-
N.S. government funding new treatment for prostate cancer
07 Feb 2025 16:50 GMT
… was part of clinical trial for a treatment for prostate cancer. Photo by Ryan … participate in a clinical trial for a treatment for prostate cancer.
The 82-year … treatment targets the prostate cancer cells specifically.
“When the prostate cancer has spread …
-
Real-world clinical usage and efficacy of apalutamide in men with nonmetastatic castration-resistant prostate cancer: a multi-institutional study in the CsJUC.
07 Feb 2025 13:07 GMT
… men with nonmetastatic castration-resistant prostate cancer (nmCRPC).
We retrospectively reviewed the … comparable with that reported in clinical trial results.
Japanese journal of clinical …
-
Medical news in brief: Sickle cell treatment, prostate cancer, patient complaints, and other stories
06 Feb 2025 22:19 GMT
Sickle cell disease gene editing therapy is approved
In final draft guidance the National Institute for Health and Care Excellence has approved a one-off gene editing therapy to treat severe sickle cell disease (SCD) in people aged 12 and over. Data …
-
Erleada Combo Shows Comparable Quality of Life Outcomes in Prostate Cancer
06 Feb 2025 03:16 GMT
… patients with advanced castration-sensitive prostate cancer, health-related quality of life …
ADT: lowers androgens to slow prostate cancer.
The APA alone and AAP … Therapy for Advanced Prostate Cancer: Secondary Analysis of a Randomized Clinical Trial” by Dr …
-
MD Anderson Research Highlights for February 10, 2025
11 Feb 2025 00:42 GMT
… favorable results in treating oligometastatic prostate cancer (Abstract 15)
While targeted … care for patients with oligometastatic prostate cancer (omPC), researchers now are … consortium, focusing on five randomized clinical trials. For the first time, they …
-
Flatiron Health Announces Research to Be Presented at American Society of Clinical Oncology Genitourinary Cancers Symposium
10 Feb 2025 22:27 GMT
… with metastatic castration-resistant prostate cancer in the community … with metastatic castration-resistant prostate cancer in the US, …
Poster Session A: Prostate Cancer Track
Abstract #74
Poster … evidence, and breakthroughs in clinical trials, we continue to …
-
$5 Million Gift from Lorraine and Bill Dodero Creates One-of-a-Kind Limb Preservation Center at University Hospitals Harrington Heart & Vascular Institute
10 Feb 2025 16:01 GMT
… breast cancer, colon cancer, and prostate cancer combined. Successfully restoring blood flow … PROMISE II U.S. pivotal clinical trial which found the novel LimFlow … more than 3,000 active clinical trials and research studies underway. UH …
About
© 1995-2025